...
首页> 外文期刊>Biological & pharmaceutical bulletin >Hepatoprotective effects of phloridzin on hepatic fibrosis induced by carbon tetrachloride against oxidative stress-triggered damage and fibrosis in rats
【24h】

Hepatoprotective effects of phloridzin on hepatic fibrosis induced by carbon tetrachloride against oxidative stress-triggered damage and fibrosis in rats

机译:菲利津对四氯化碳诱导的肝纤维化的抗氧化应激触发的损伤及肝纤维化的肝保护作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was to study the hepatoprotective effects of phloridzin (PHL) on hepatic fibrosis induced by carbon tetrachloride (CCl _4) in rats, on the basis of this investigation, the possible mechanism of PHL was elucidated. Male Sprague Dawley (SD) rats were randomly divided into six groups: control, model, PHL-L, PHL-M, PHL-H and colchine. All rats except control group were intraperitoneally injected with CCl4, and control rats were injected with olive oil, twice a week for eight weeks. At the same time, the rats were orally given homologue drugs once a day, respectively. Hepatoprotective effects of PHL were evaluated by liver weight indexes, biochemical values, total antioxidant capacity and total-superoxide dismutase, histopathological observations, hepatic fibrosis, and the hepatic fibrosis relative gene and protein expressions. PHL significantly improved hepatic function; remarkably decreased serum hyaluronic acid (HA), transforming growth factor-β1 (TGF-β1), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and liver tissues hydroxyproline, malondialdehyde (MDA) levels, increased glutathione peroxidase (GSH-Px), totalantioxygen capacity (T-AOC) and total-superoxide dismutase (T-SOD) contents of liver tissues; Real-time polymerase chain reaction (PCR) and immunohisto-chemical results showed PHL might markedly reverse the up-regulated mRNA and protein expressions of the α-smooth muscle actin (SMA), TGF-β1 and tissue inhibitor of metalloproteinase-1 (TIMP1), up-regulate the matrix metalloproteinase-1 (MMP1) mRNA and protein expressions. Histopathological observations provided supportive evidence for biochemical analyses and the hepatic fibrosis relative gene and protein expressions, and with the dose of PHL increasing, the aforesaid improvement became more and more strong. The studies demonstrated that PHL exerted beneficially hepatoprotective effects on hepatic fibrosis induced by CCl _4, mainly enhancing antioxidant capacity of liver organizations, reduce the level of lipid peroxidation induced by CCl _4, and protect hepatocyte membranes from damage, and alleviate hepatic fibrosis.
机译:本研究旨在研究Phloridzin(PHL)对四氯化碳(CCl _4)诱导的大鼠肝纤维化的肝保护作用,在此基础上,阐明了PHL的可能机制。将雄性Sprague Dawley(SD)大鼠随机分为六组:对照组,模型,PHL-L,PHL-M,PHL-H和秋水仙碱。除对照组外,所有大鼠腹膜内注射CCl4,对照组大鼠注射橄榄油,每周两次,共8周。同时,每天分别给大鼠口服一次同源药物。通过肝脏重量指数,生化值,总抗氧化能力和总超氧化物歧化酶,组织病理学观察,肝纤维化以及肝纤维化相关基因和蛋白质表达来评估PHL的肝保护作用。 PHL可显着改善肝功能;血清透明质酸(HA),转化生长因子-β1(TGF-β1),天冬氨酸转氨酶(AST),丙氨酸转氨酶(ALT)和肝组织羟脯氨酸,丙二醛(MDA)水平显着降低,谷胱甘肽过氧化物酶(GSH-Px)升高,肝组织的总抗氧能力(T-AOC)和总超氧化物歧化酶(T-SOD)含量;实时聚合酶链反应(PCR)和免疫组织化学结果显示,PHL可能显着逆转α平滑肌肌动蛋白(SMA),TGF-β1和金属蛋白酶-1(TIMP1)的mRNA和蛋白表达上调),上调基质金属蛋白酶-1(MMP1)mRNA和蛋白质表达。组织病理学观察为生化分析,肝纤维化相关基因和蛋白质表达提供了支持性证据,随着PHL剂量的增加,上述改善越来越明显。研究表明,PHL对CCl _4诱导的肝纤维化具有有益的保肝作用,主要是增强肝脏组织的抗氧化能力,降低CCl _4诱导的脂质过氧化水平,保护肝细胞膜免受损害,并减轻肝纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号